Diabetes insipidus: Nursing process (ADPIE)

1,679views

Diabetes insipidus: Nursing process (ADPIE)

Synthesis Of Nursing Practice

Synthesis Of Nursing Practice

Left-sided heart failure: Nursing process (ADPIE)
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Normal heart sounds
Abnormal heart sounds
Anatomy of the heart
Congenital heart defects: Clinical
Cardiac conduction system
Post-COVID syndrome: Heart, lungs and clotting
Heart blocks: Pathology review
Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Antihyperlipidemics - Statins: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Applying sterile gloves
Cardioversion
Maintaining an airway
Removing an intravenous line
Venipuncture for blood sampling
Clinical Skills: Abdominal Assessment
Clinical skills: Medication administration - Giving transcutaneous medication
Clinical skills: Patient controlled analgesia
COVID-19: Nursing

Notes

DIABETES INSIPIDUS

KEY POINTS
NOTES
PATIENT REPORT
  • 30-year-old man
  • Traumatic brain injury 4 months ago
  • Increased thirst, increased urine output, frequent nighttime urination
  • Tired
  • Sodium: 147 mEq/L (147 mmol/L)
  • Glucose: 100 mg/dL (5.6 mmol/L)
  • Osmolality: 312 mOsm/kg
  • Specific gravity: 1.001
  • Urine osmolality: 248 mOsm/kg
  • Diagnosis: central diabetes insipidus

PATHOPHYSIOLOGY
  • Diabetes insipidus
    • Excessive water loss 
    • Four types
      • Central
      • Nephrogenic
      • Gestational
      • Dipsogenic
  • Hypothalamus
    • Contains osmoreceptors 
      • Sense osmolality of blood
    • Dehydration
      • Osmoreceptors stimulate pituitary to release antidiuretic hormone (ADH)
      • ADH works on kidneys to decrease water excretion and increase water reabsorption
      • Osmoreceptors also stimulate thirst
  • Signs and symptoms
    • Large quantities of urine
    • Increased plasma osmolality
    • Excessive drinking
  • Complications
    • Dehydration
    • Electrolyte imbalances
  • Diagnosis
    • History
    • Physical assessment
    • Laboratory tests
    • Fluid deprivation test
    • Brain imaging
  • Treatment
    • Medication
    • Behavioral therapy
    • Manage underlying condition

ASSESSMENT
  • Temperature: 98.6 F (37.0 C)
  • Heart rate: 88
  • Respiratory rate: 14
  • Blood pressure: 105/75 mmHg
  • Oxygen saturation: 95% room air
  • Dry mucous membranes, poor skin turgor

NURSING DIAGNOSES
  • Deficient fluid volume related to inability to conserve fluid
  • Risk for electrolyte imbalance related to compromised endocrine regulatory mechanism
  • Disturbed sleep pattern related to nocturia
  • Ineffective health maintenance related to deficient knowledge

PLANNING
  • Maintain adequate fluid balance
  • Maintain normal electrolyte balance
  • Verbalize understanding of diabetes insipidus management
  • Identify symptoms that need attention
  • Sleep pattern will normalize

IMPLEMENTATION
  • Administer medications as ordered
  • Explain self-administration
  • Explain when to seek emergency care and notify healthcare provider
  • Instruct on follow-up

EVALUATION
  • Fluid and electrolyte levels normalizing
  • Urine output decreased
  • Urine more concentrated
  • Urine specific gravity: 1.020
  • Urine osmolality: 720 mOsm/kg
  • Sodium: 144 mEq/L (144 mmol/L)
  • Serum osmolality: 297 mOsm/kg

Transcript

Watch video only

Harvey Nguyen is a 30-year-old male client who suffered a traumatic brain injury during a skiing accident 4 months ago.

He presents to his primary care physician, or PCP, with a report of increased thirst, increased urine output, and frequent nighttime urination.

He says he doesn’t go anywhere without a water bottle and always needs to know where the restroom is when he is away from home.

He says that he is tired all the time because he has to make frequent trips to the bathroom during the night.

His laboratory results are serum sodium 147 mEq/L; serum glucose 100 mg/dL; serum osmolality 312 mOsm/kg; urine specific gravity 1.001; and urine osmolality 248 mOsm/kg.

His PCP refers him to an endocrinologist who admits Harvey to the medical unit for a water deprivation test which confirms the diagnosis of central diabetes insipidus.

Diabetes insipidus is a condition characterized by excessive water loss through urine because the kidneys don’t reabsorb enough water.

Now, the primary hormone that regulates water reabsorption and balance in the body is ADH, also called vasopressin.

ADH is normally produced by the hypothalamus and is stored in the posterior pituitary, which are both located within the brain. To do this, the hypothalamus contains osmoreceptors, which are able to sense the osmolality of the blood.

The normal blood osmolality value is between 285 and 295 mOsm/kg. Now, when a person is dehydrated, osmolality increases, so osmoreceptors sense this and, in response, stimulate the pituitary to release the stored ADH into the blood.

ADH then travels to the kidneys to decrease water excretion in urine, and increase water reabsorption back into the blood, which ultimately helps restore normal blood osmolality.

In addition, osmoreceptors trigger the sensation of thirst. After the person drinks water, the osmolality returns to normal, and ADH secretion stops.

There are four types of diabetes insipidus. The first type is central diabetes insipidus, which is caused by a problem in the hypothalamus or pituitary gland, preventing ADH production or ADH release.

This can be due to a head injury, neurosurgery, brain tumor, vascular lesions like aneurysms, as well as due to an infection like meningitis or encephalitis, autoimmune conditions, or sometimes, the cause can be idiopathic.

The second type is nephrogenic diabetes insipidus, which is caused by a problem with the kidneys themselves, making them unresponsive to ADH.

This may be due to a genetic defect of the vasopressin receptors, or kidney disorders like polycystic kidney disease, as well as medications like lithium.

The third type is gestational diabetes insipidus, which occurs during pregnancy, because the placenta releases an enzyme called vasopressinase that breaks down ADH.

In other cases, pregnant clients generally produce more prostaglandins, which reduce kidney sensitivity to ADH.

Finally, the fourth type is dipsogenic diabetes insipidus, also called psychogenic or primary polydipsia, which is caused by drinking far too much water and it is often associated with a psychiatric disorder, such as schizophrenia, but can also be caused by damage to the hypothalamic osmoreceptors that regulate the feeling of thirst.

The most characteristic symptom of diabetes insipidus is that clients produce unusually large quantities of urine, which is called polyuria. A client with diabetes insipidus typically makes over 3 liters of dilute urine each day.

As a consequence, plasma osmolality increases, so osmoreceptors trigger thirst, causing the client to drink excessive amounts of water, which is called polydipsia.

Despite this, the kidneys remain unable to reabsorb water. As a result, diabetes insipidus can quickly lead to complications like dehydration, and low blood pressure. Clients may also develop electrolyte imbalances, such as hypernatremia or high blood sodium.

Now, acute hypernatremia causes neurological symptoms that range from lethargy, weakness, altered mental status, and irritability, to severe symptoms, like seizures and coma.

In addition, acute hypernatremia rapidly pulls water out of brain cells, so the brain as a whole shrinks. As a result, blood vessels within the brain may rupture and cause intracerebral and subarachnoid hemorrhages.

The diagnosis of diabetes insipidus typically starts with history and physical examination. In addition, a blood test would show an increased blood osmolality in central, nephrogenic, and gestational diabetes insipidus.

Sources

  1. "Ackley and Ladwig’s Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care, 13th edition" Mosby (2022)
  2. "Diabetes Insipidus: New Concepts for Diagnosis" Neuroendocrinology (2020)
  3. "Diabetes insipidus related to sedation in the intensive care unit: A review of the literature" J Crit Care (2023)
  4. "Harrison’s Principles of Internal Medicine, 21st edition" McGraw Hill / Medical (2022)
  5. "Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management" Cureus (2021)
  6. "Critical Care Nursing: Diagnosis and Management, 9th edition" Elsevier (2021)
  7. "Diabetes Insipidus" Pediatr Rev (2020)